Novo Nordisk

Dr. Mehmet Oz was front and center Thursday as President Donald Trump unveiled a new deal with two…

Fangzhou Inc. SHANGHAI, Nov. 07, 2025 (GLOBE NEWSWIRE) — Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a…

When President Trump told an audience in October that he hoped to cut the cost of Ozempic down…

WASHINGTON — The Trump administration announced a deal Thursday to expand access to popular obesity drugs made by…

Novo Nordisk reported Q3 2025 earnings on November 5, showing continued strong demand for its weight-loss drug Wegovy,…

Pfizer on Monday said it filed a second lawsuit against Novo Nordisk and obesity startup Metsera, alleging that…

As weight loss market rival Novo Nordisk drew headlines for starting a bidding war over a potential $9bn…

By Mrinalika Roy and Patrick Wingrove (Reuters) -Eli Lilly said on Thursday its experimental weight-loss pill met most…

Novo Nordisk NVO is a dominant player in the cardiometabolic space, mainly due to the encouraging uptake of its…

Moderna could tumble once again, if there’s a lack of positive news in its upcoming earnings release. Novo…

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Costco…

Novo Nordisk could get its momentum back with its oral Wegovy pill. Danaher is a proven market-beater trading…

Dr. Oz made a stunning estimate after Trump’s obesity drug deals: ’135 billion’ pounds?!